Bilirubin is a breakdown product of hemoglobin, which becomes soluble in water interacting with glucuronic acid in liver and comes out in bile. Some babys have a neonatal hyperbilirubinaemia, where the newborn’s liver is not able to properly process the bilirubin causing jaundice. In this case neuborns need a therapy, which reduces bilirubin. Phototherapy is the safest method as billirubin passes into water – soluble state through photochemical reaction and comes out in bile and urine.
U-1133 is used for infant hyperbilirubinemial treatment Compatible with any incubator Blue light lamps (adjustable angle and height) Wavelength – Blue light 420 – 470 mn Stand with 4 pcs casters with brakes Adjustable height and angle of the lamp module
Features: U-1131 is used for infanthyperbilirubinemial treatment Compatible with any incubator Blue light lamps (adjustable angle and height) Lamps quantity 5 lamps × 20 W (blue light) WL Blue light 420 – 470mn Radiant power 500 mkW/cm² Angle of the lamp rotation Any angle or fixed angle Electronic timer Up to 10000 hours Electronic power supply […]
We were happy to present our product portfolio to a broad international audience at the Arab Health 2022 and consider the exhibition as a great success for DIXION. This year it attracted 78000 professional trade visitors from over 60 countries. Arab Health offers excellent networking opportunities in the medical devices sector. DIXION plays an active […]
Dear customers, business partners and colleagues, Despite the pandemic and the MEDICA which was canceled last year, we are all the more looking forward to this year’s trade fair. We would be happy to invite you to our booth in hall 10 E19 from 15 to 18 November. Our competent specialists will introduce you to […]
This year, the Arab Health Trade Fair runs from June 21 to 24, as it was brought in since February of this year due to coronavirus infection. Despite the complicated circumstances associated with Covid 19, the exhibition was visited by 78,000 visitors from 66 countries of the world. We would like to take the opportunity […]